Epigenetic induction of adaptive immune response in multiple myeloma: sequential azacitidine and lenalidomide generate cancer testis antigen-specific cellular immunity.
作者:
主题词
成年人(Adult);老年人(Aged);抗原, 肿瘤(Antigens, Neoplasm);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);阿扎胞苷(Azacitidine);硼酸化物(Boronic Acids);DNA甲基化(DNA Methylation);地塞米松(Dexamethasone);多柔比星(Doxorubicin);用药计划表(Drug Administration Schedule);后成说, 遗传(Epigenesis, Genetic);女(雌)性(Female);人类(Humans);免疫, 细胞(Immunity, Cellular);淋巴细胞输注(Lymphocyte Transfusion);男(雄)性(Male);中年人(Middle Aged);多发性骨髓瘤(Multiple Myeloma);外周血干细胞移植(Peripheral Blood Stem Cell Transplantation);浆细胞(Plasma Cells);前瞻性研究(Prospective Studies);吡嗪类(Pyrazines);T细胞抗原受体特异性(T-Cell Antigen Receptor Specificity);沙立度胺(Thalidomide);移植, 自体(Transplantation, Autologous)
DOI
10.1111/j.1365-2141.2012.09225.x
PMID
22816680
发布时间
2021-10-21
- 浏览99
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文